William H. Carson - 17 Jun 2022 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role
Director
Signature
/s/ Elisabeth Leiderman, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jun 2022
Net transactions value
$0
Form type
4
Filing time
21 Jun 2022, 18:54:29 UTC
Previous filing
13 Jun 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 17 Jun 2022 Common Stock 10,000 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 17, 2022 for 10,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.